|
|
Volumn 3, Issue 5, 2001, Pages 355-360
|
|
Impact of molecular medicine on neuropsychiatry: the clinician's perspective.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
GENETIC HETEROGENEITY;
GENETICS;
HUMAN;
MENTAL DISEASE;
METHODOLOGY;
MOLECULAR BIOLOGY;
NEUROLOGY;
PHENOTYPE;
PSYCHIATRY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
GENETIC HETEROGENEITY;
HUMANS;
MENTAL DISORDERS;
MOLECULAR BIOLOGY;
NEUROLOGY;
PHENOTYPE;
PSYCHIATRY;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 1842739868
PISSN: 15233812
EISSN: None
Source Type: Journal
DOI: 10.1007/s11920-996-0026-y Document Type: Review |
|
Times cited : (1)
|
|
References (38)
|
